Loading companies…

Compumedics Ltd ASX:CMP

0 opened or increased0 held1 reduced or exitedlatest position by manager, past 12 months90 days: 0 increased, 0 reduced. 1 managers in total.

Position history by manager 1 managersSelect a point to see the comment

Opened or increasedHeldReduced or exited Start or end of the position not reported

2023202420252026

21 Nov 2022 to today

Commentary Showing 2 of 3

DateManagerActionSummary

31 Oct 2025Mereweather CapitalExitMereweather Capital exited its small position in Compumedics Ltd following a brief share price rally after the company raised capital from shareholders. Mereweather Capital acknowledges making a decent return on the position but concedes the original investment thesis did not play out as intended — COVID disrupted the global business, and while gross margins recovered, the fund did not anticipate the company's heavy investment in sales and marketing, which more than doubled from $8.5 million in FY19 to $18 million in FY25, requiring multiple capital raisings. The fund did not participate in the most recent raise and exited at the post-raise share price spike.

Medical DevicesMonthly Report, price recorded $0.35

The source document link is a Pro feature

28 Feb 2025Mereweather CapitalHeldThe fund manager continues to hold Compumedics (CMP) despite a weak first half result with revenue down 11% and a $1.1 million loss as the company front-loads costs to build a U.S. sales team for the home sleep testing industry. The manager notes sales orders taken in advance were up 73% year-on-year and management has provided guidance of approximately $32 million revenue and approximately $2.5 million profit for the second half versus $23.5 million revenue and a $1.1 million loss in the first half.

Monthly Report, price recorded $0.26

The source document link is a Pro feature

1 more comments on CMPPro shows every comment, with a link to each source document.

Upgrade to Pro

First mention by manager

Price recorded at each manager's first comment

Price at first mentionThe share price recorded when each of 1 managers first commented on CMP.

View Pro

About Compumedics Ltd

Healthcare, Healthcare Equipment and Supplies

Compumedics (ASX:CMP), a developer of medical diagnostic technology, has been held by small-cap specialists, though the investment case has disappointed. In October 2025, Mereweather Capital reported exiting its small position after the company again raised capital from shareholders and the shares briefly rallied. While the manager made a reasonable return, it acknowledged the original thesis had not played out, as COVID disrupted Compumedics' global business and profits stayed muted by elevated shipping costs. Compumedics operates in the Healthcare sector within the Healthcare Equipment and Supplies industry, and Thesis Tracker has captured 3 comments from 1 fund manager, Mereweather Capital. Founded in 1987 by David Burton and headquartered in Abbotsford, Victoria, Compumedics develops, manufactures and distributes computer-based diagnostic equipment for sleep, neurology and cardiology, supplying hospitals and clinics worldwide.

Market cap: $48m
Price to earnings: 263.9x
Return on equity: 1.0%
Dividend yield: 0.0%
Price to book: 1.87x
Net margin: 0.4%
52-week range: $0.22 to $0.45

Company figures as of 15 Oct 2026. For information only.

Questions

Who is investing in Compumedics Ltd (ASX:CMP)?

Fund managers including Mereweather Capital have invested in Compumedics Ltd (ASX:CMP).

What opportunities or catalysts do fund managers highlight for Compumedics Ltd?

The most recent fund manager commentary does not highlight new catalysts. Mereweather Capital's exit note focuses on lessons from the position rather than upcoming opportunities, though it indicates the original case was built on growth in Compumedics' global sleep and neurology diagnostics business.

What are the key risks to the Compumedics Ltd investment thesis, according to fund managers?

Mereweather Capital cites repeated capital raisings from shareholders, the disruption COVID caused to the company's global operations and persistently muted profitability due to elevated shipping costs, concluding in hindsight that the original investment thesis did not play out as intended.

What does Compumedics Ltd (ASX:CMP) do?

Compumedics Ltd. develops, manufactures, and distributes computer-based medical diagnostic equipment specializing in sleep, neurology, and cardiology. Founded in 1987 by David Burton and headquartered in Abbotsford, Australia, the company provides innovative healthcare technologies globally. Compumedics operates through three primary geographical segments: Americas (United States, Canada, Latin America), Australia and Asia Pacific (including Japan and China), and Europe and the Middle East. The firm focuses on delivering advanced medical diagnostic solutions to clinical and research markets worldwide.

General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.

11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.

Disclaimer Terms of Use Privacy Complaints Contact

Loading…